Literature DB >> 32317355

EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke.

Claudio L A Bassetti1,2,3, Winfried Randerath4,3, Luca Vignatelli5, Luigi Ferini-Strambi6, Anne-Kathrin Brill7, Maria R Bonsignore8, Ludger Grote9, Poul Jennum10, Didier Leys11, Jens Minnerup12, Lino Nobili13, Thomy Tonia14, Rebecca Morgan15, Joel Kerry16, Renata Riha17,18, Walter T McNicholas19,20,21,22, Vasileios Papavasileiou23,24,22.   

Abstract

Sleep disorders are highly prevalent in the general population and may be linked in a bidirectional fashion to stroke, which is one of the leading causes of morbidity and mortality.Four major scientific societies established a task force of experts in neurology, stroke, respiratory medicine, sleep medicine and methodology, to critically evaluate the evidence regarding potential links and the impact of therapy. 13 research questions were evaluated in a systematic literature search using a stepwise hierarchical approach: first, systematic reviews and meta-analyses; second, primary studies post-dating the systematic reviews/meta-analyses. A total of 445 studies were evaluated and 88 included. Statements were generated regarding current evidence and clinical practice.Severe obstructive sleep apnoea (OSA) doubles the risk for incident stroke, especially in young to middle-aged patients. Continuous positive airway pressure (CPAP) may reduce stroke risk, especially in treatment-compliant patients. The prevalence of OSA is high in stroke patients and can be assessed by polygraphy. Severe OSA is a risk factor for recurrence of stroke and may be associated with stroke mortality, while CPAP may improve stroke outcome. It is not clear if insomnia increases stroke risk, while pharmacotherapy of insomnia may increase it. Periodic limb movements in sleep (PLMS), but not restless limb syndrome (RLS), may be associated with an increased risk of stroke. Preliminary data suggest a high frequency of post-stroke insomnia and RLS and their association with a less favourable stroke outcome, while treatment data are scarce.Overall, the evidence base is best for OSA relationship with stroke and supports active diagnosis and therapy. Research gaps remain especially regarding insomnia and RLS/PLMS relationships with stroke. The article has been co‐published with permission in the European Respiratory Journal and the European Journal of Neurology. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article.
Copyright ©European Academy of Neurology and European Respiratory Society 2020.

Entities:  

Mesh:

Year:  2020        PMID: 32317355     DOI: 10.1183/13993003.01104-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

Review 1.  Current and novel treatment options for obstructive sleep apnoea.

Authors:  Winfried Randerath; Jan de Lange; Jan Hedner; Jean Pierre T F Ho; Marie Marklund; Sofia Schiza; Jörg Steier; Johan Verbraecken
Journal:  ERJ Open Res       Date:  2022-06-27

2.  Usefulness of self-administered questionnaires in screening for direct referral for polysomnography without sleep physician review.

Authors:  Craig Hukins; Brett Duce
Journal:  J Clin Sleep Med       Date:  2022-05-01       Impact factor: 4.324

3.  Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study.

Authors:  Chung-Yao Chen; Chia-Ling Chen; Chung-Chieh Yu
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

4.  SAS Care 1: sleep-disordered breathing in acute stroke an transient ischaemic attack - prevalence, evolution and association with functional outcome at 3 months, a prospective observational polysomnography study.

Authors:  Sebastian R Ott; Francesco Fanfulla; Silvia Miano; Thomas Horvath; Andrea Seiler; Corrado Bernasconi; Carlo W Cereda; Anne-Kathrin Brill; Peter Young; Lino Nobili; Mauro Manconi; Claudio L A Bassetti
Journal:  ERJ Open Res       Date:  2020-06-15

5.  SAS CARE 2 - a randomized study of CPAP in patients with obstructive sleep disordered breathing following ischemic stroke or transient ischemic attack.

Authors:  C Bernasconi; S R Ott; F Fanfulla; S Miano; T Horvath; A Seiler; C W Cereda; A-K Brill; P Young; L Nobili; M Manconi; C L A Bassetti
Journal:  Sleep Med X       Date:  2020-10-09

6.  Recognizable Clinical Subtypes of Obstructive Sleep Apnea After Ischemic Stroke: A Cluster Analysis.

Authors:  Chung-Yao Chen; Chia-Ling Chen
Journal:  Nat Sci Sleep       Date:  2021-03-02

Review 7.  Sleep Disorders in Stroke: An Update on Management.

Authors:  Hongxia Cai; Xiao-Ping Wang; Guo-Yuan Yang
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

8.  The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial.

Authors:  Miaochan Lao; Yilu Cheng; Xinglin Gao; Qiong Ou
Journal:  BMC Pulm Med       Date:  2022-03-21       Impact factor: 3.317

Review 9.  The European Sleep Research Society - past, present and future.

Authors:  Tom Deboer; Erna Sif Arnardóttir; Hans-Peter Landolt; Pierre Hervé Luppi; Walter T McNicholas; Dirk Pevernagie; Giuseppe Plazzi
Journal:  J Sleep Res       Date:  2022-04-17       Impact factor: 5.296

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.